Psychotogenic Drug

« Back to Glossary Index

A psychotogenic drug is a substance that can trigger psychotic symptoms in vulnerable individuals. Psychosis refers to experiences such as hallucinations (seeing or hearing things that are not there), delusions (fixed false beliefs), or a significant break from shared reality. Psychotogenic drugs often increase dopamine activity in brain circuits involved in reward and salience. In people whose dopamine systems are already sensitized — as can occur in bipolar disorder or schizophrenia — this additional stimulation can lower the threshold for mania or psychosis. Importantly, these drugs do not cause psychosis in everyone who uses them; the risk depends on biological vulnerability, dose, and frequency of use. Effects may be temporary and are dose- and context-dependent — more likely with high doses, frequent use, early age of exposure, sleep deprivation, or in people with a personal or family history of  psychotic or mood disorders. Common psychotogenics:

• Stimulants (amphetamines, cocaine),
• Hallucinogens
• High-potency cannabis
• Prescription medications misused or taken at high dose (corticosteroids, dopaminergics)

Clinical settings or research distinguish substances precipitating psychosis from ones worsening existing symptoms or mimicking psychotic-like experiences — relevant to harm reduction, informed consent, and individualized risk. In addition:

• Substance-induced psychosis are hallucinations, delusions, or disorganized thinking that occur as a direct result of using, reducing, or stopping a substance. These psychotic symptoms arise during intoxication or withdrawal and are necessarily due to a primary psychotic disorder. Symptoms can resolve after the substance leaves the body, though in some they can persist or unmask an underlying vulnerability.
• Vulnerability–stress model is a framework to explain why some develop mental health symptoms while others don’t—proposing differing baseline vulnerability or when stressors exceed coping capacity. Substances, including cannabis, can function as stressors increasing symptom risk in those with higher vulnerability, while having little effect on others.
• Dose–response relationship describes how a substance’s amount or frequency affects the likelihood or intensity of its effects. Higher doses or more frequent use are generally associated with a greater risk of adverse outcomes, including psychotic symptoms. The relationship is not always linear, but increased exposure typically raises risk.